Hugo Donato

876 total citations
28 papers, 585 citations indexed

About

Hugo Donato is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, Hugo Donato has authored 28 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Physiology and 7 papers in Genetics. Recurrent topics in Hugo Donato's work include Platelet Disorders and Treatments (10 papers), Blood groups and transfusion (10 papers) and Erythrocyte Function and Pathophysiology (8 papers). Hugo Donato is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Blood groups and transfusion (10 papers) and Erythrocyte Function and Pathophysiology (8 papers). Hugo Donato collaborates with scholars based in Argentina, Panama and United States. Hugo Donato's co-authors include Thomas Kühne, Paul Imbach, Johannes Rischewski, Willi Berchtold, Runhui Wu, Francesco Rodeghiero, Meera Chitlur, Lisa A. Michaels, Byron M. Espina and George R. Buchanan and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and The Journal of Pediatrics.

In The Last Decade

Hugo Donato

25 papers receiving 557 citations

Peers

Countries citing papers authored by Hugo Donato

Since Specialization

Citations

This map shows the geographic impact of Hugo Donato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Donato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Donato more than expected).

Fields of papers citing papers by Hugo Donato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Donato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Donato. The network helps show where Hugo Donato may publish in the future.

Co-authorship network of co-authors of Hugo Donato

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Donato. A scholar is included among the top collaborators of Hugo Donato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Donato. Hugo Donato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neonatal thrombocytopenia: A review. II. Non-immune thrombocytopenia; platelet transfusion 2021 ·Archivos Argentinos de Pediatria ·Hugo Donato	6
2	Trombocitopenia inmune. Guía de diagnóstico y tratamiento 2019 ·Archivos Argentinos de Pediatria ·(unknown), Hugo Donato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	A comparative prospective observational study of children and adults with immune thrombocytopenia: 2‐year follow‐up 2018 ·American Journal of Hematology ·Alexandra Schifferli, Andreas Holbro, Meera Chitlur, Michael Coslovsky, Paul Imbach, Hugo Donato, Mohsen Saleh Elalfy, (unknown), John D. Grainger, Susanne Holzhauer, (unknown), Francesco Rodeghiero, Marco Ruggeri, Hannah Tamary, (unknown), Runhui Wu, Thomas Kühne, (unknown)	39
4	Deficiencia de hierro y anemia ferropénica. Guía para su prevención, diagnóstico y tratamiento. Resumen ejecutivo 2017 ·Archivos Argentinos de Pediatria ·Hugo Donato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Patricia Sosa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
5	Thrombosis in newborn infants 2016 ·Archivos Argentinos de Pediatria ·(unknown), (unknown), Hugo Donato	17
6	Trombosis en el recién nacido 2016 ·Archivos Argentinos de Pediatria ·(unknown), (unknown), (unknown), Hugo Donato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
7	Red blood cell aquaporin-1 expression is decreased in hereditary spherocytosis 2016 ·Annals of Hematology ·(unknown), (unknown), Daniela Vittori, Liliana Solari, (unknown), (unknown), (unknown), (unknown), Hugo Donato, Alcira Nesse	10
8	Use of capillary blood to diagnose hereditary spherocytosis 2012 ·Pediatric Blood & Cancer ·(unknown), Liliana Solari, (unknown), (unknown), (unknown), Hugo Donato	12
9	A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5′-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina 2010 ·Annals of Hematology ·(unknown), Liliana Solari, Daiana Vota, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniela Vittori, (unknown), Alcira Nesse, Hugo Donato	48
10	Diagnosis and management of chronic ITP: comments from an ICIS expert group 2010 ·Annals of Hematology ·John D. Grainger, Paula Bolton‐Maggs, Bertrand Godeau, (unknown), Hugo Donato, Mohsen Saleh Elalfy, Ina Hainmann, Axel Matzdorff, (unknown), Alicia Rovó, André Tichelli	13
11	Comparación entre hierro polimaltosa y sulfato ferroso para el tratamiento de la anemia ferropénica: estudio prospectivo aleatorizado 2007 ·Archivos Argentinos de Pediatria ·Hugo Donato, (unknown), (unknown), (unknown)	2
12	Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data 2007 ·Vaccine ·Robert P. Wise, Jan Bonhoeffer, Judy A. Beeler, Hugo Donato, Peter Downie, Dana C. Matthews, Vitali Pool, (unknown), Terhi Tapiainen, Frederick Varricchio	21
13	Splenectomy and spontaneous remission in children with chronic idiopathic thrombocytopenic purpura 2006 ·Pediatric Blood & Cancer ·Hugo Donato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	24
14	Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group 2006 ·Pediatric Blood & Cancer ·Thomas Kühne, Victor S. Blanchette, George R. Buchanan, Ugo Ramenghi, Hugo Donato, R. Y. J. Tamminga, Johannes Rischewski, Willi Berchtold, Paul Imbach	72
15	Erythropoietin: an update on the therapeutic use in newborn infants and children 2005 ·Expert Opinion on Pharmacotherapy ·Hugo Donato	2
16	α-Interferon Therapy Induces Improvement of Platelet Counts in Children With Chronic Idiopathic Thrombocytopenic Purpura 2001 ·The American journal of pediatric hematology/oncology ·Hugo Donato, (unknown), (unknown), Alicia Rovó, (unknown), (unknown), (unknown), (unknown), (unknown), Pablo Rendo	8
17	Effect of Early Versus Late Administration of Human Recombinant Erythropoietin on Transfusion Requirements in Premature Infants: Results of a Randomized, Placebo-Controlled, Multicenter Trial 2000 ·PEDIATRICS ·Hugo Donato, Néstor Vain, Pablo Rendo, (unknown), Luis Prudent, (unknown), (unknown), Carmen Vecchiarelli, (unknown), Cecilia Garcı́a, (unknown), Claudio Solana, (unknown)	71
18	Low levels of serum erythropoietin in children with endemic hemolytic uremic syndrome 1998 ·Pediatric Nephrology ·Ramón Exeni, Hugo Donato, Pablo Rendo, (unknown), (unknown), (unknown), Andrea Exeni, (unknown), (unknown), (unknown)	12
19	Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease. 1997 ·Journal of Clinical Oncology ·S Pavlovsky, Enrique Schvartzman, Francisco Lastiri, (unknown), Claudia Corrado, Elsa Raslawski, (unknown), (unknown), (unknown), (unknown), Stefania Bruno, (unknown), (unknown), Hugo Donato, Eduardo Dibar, (unknown)	19
20	Tratamiento de la aplasia medular con globulina antilinfocitaria 1988 ·Medicina-buenos Aires ·(unknown), (unknown), (unknown), (unknown), Pablo Rendo, (unknown), Hugo Donato, (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact